FGFR2 Is Amplified in the NCI-H716 Colorectal Cancer Cell Line and Is Required for Growth and Survival-Reference-Cited by-同舟云学术

FGFR2 Is Amplified in the NCI-H716 Colorectal Cancer Cell Line and Is Required for Growth and Survival

Published:2014-06-26 Issue:6 Volume:9 Page:e98515
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mathur Anjili,Ware Christopher,Davis Lenora,Gazdar Adi,Pan Bo-Sheng,Lutterbach Bart

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging;JB O’Connell;J Natl Cancer Inst,2004

2. A genetic model for colorectal tumorigenesis;ER Fearon;Cell,1990

3. High frequency of mutations of the PIK3CA gene in human cancers;Y Samuels;Science,2004

4. Mutations of the BRAF gene in human cancer;H Davies;Nature,2002

5. Transforming growth factor-alpha production and autoinduction in a colorectal carcinoma cell line (DiFi) with an amplified epidermal growth factor receptor gene;S Untawale;Cancer Res,1993

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the role of C1GALT1 in abnormal glycosylation and colorectal cancer progression;Frontiers in Oncology;2024-04-18

2. Identification of Piperazinyl–Difluoro-indene Derivatives Containing Pyridyl Groups as Potent FGFR Inhibitors against FGFR Mutant Tumor: Design, Synthesis, and Biological Evaluation;Journal of Medicinal Chemistry;2024-01-31

3. Expansion of the complex genotypic and phenotypic spectrum of FGFR2-associated neurocutaneous syndromes;Human Genetics;2024-01-24

4. Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling;Frontiers in Pharmacology;2024-01-10

5. FGFR families: biological functions and therapeutic interventions in tumors;MedComm;2023-09-23